title: Regulation of orotic acid biosynthesis and excretion induced by oral glutamine administration in mice.
abstract: Glutamine, the most abundant amino acid in blood and tissues, is degraded by the renal and splanchnic tissues, especially the small intestinal mucosa. Due to the activity of glutaminase, it may be broken down in these tissues and contribute to ammoniagenicity. Glutamine, either directly or through ammonia production, may act as a nitrogenous source for pyrimidine biosynthesis. We have evaluated the effect of glutamine on orotate metabolism in mice, by gavaging (ig) L-glutamine, 1.0 to 4.0 mmol/100 g of body wt/day, during 6 weeks of experimentation. Glutamine at doses of 2.5 to 4.0 mmol/100 g of body wt caused a significant increase in plasma ammonia and urinary orotate. The regulation of the orotic acid biosynthesis and excretion was studied by testing the effects of various inhibitors in mice force-fed with glutamine (4 mmol/100 g of body wt, ig). The orotic aciduria was insensitive to acivicin (1 and 5 mg/100 g of body wt, ip), a specific inhibitor of the cytoplasmic carbamyl phosphate synthetase-II, thus pointing toward the mitochondrion as the principal source of carbamyl phosphate. Cycloheximide (15 and 100 mg/kg of body wt, ip) caused a significant decrease in urinary orotate indicating that the induction of orotate synthesis by glutamine may be associated with the translation of a specific protein. However, orotate excretion was significantly decreased by N-(phosphonoacetyl)-L-aspartate (PALA) (5 mg/100 g of body wt, ip) due to its inhibitory effect on the aspartate transcarbamylase activity. There was a significant increase of urinary orotate following ingestion of adenine supplemented diets (0.1% and 0.2%), suggesting the blockage of the utilization of orotate for nucleotide biosynthesis by glutamine. Since orotate synthesis may also be influenced by ornithine metabolism, we evaluated the effect of glutamine administration on various ornithine-metabolizing enzymes. There was a decrease in hepatic ornithine decarboxylase activity with no change in hepatic ornithine aminotransferase activity following the administration of glutamine. This observation indicates that an increased metabolic utilization of ornithine is not responsible for the increase in orotate excretion, which may be caused principally through an effect of glutamine on mitochondrial carbamyl phosphate synthesis.
authors.affiliation: Centre de recherche, Hôpital Ste-Justine, Montreal, Quebec, Canada.
authors.forename: J
authors.initials: J
authors.lastname: Nelson
authors.forename: I A
authors.initials: IA
authors.lastname: Qureshi
authors.forename: V S
authors.initials: VS
authors.lastname: Ghole
authors.forename: D R
authors.initials: DR
authors.lastname: Deshmukh
mesh_terms: D000284:Administration, Oral; D000641:Ammonia / Q000097:blood; D000818:Animals; D002223:Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing) / Q000037:antagonists & inhibitors; D002221:Carbamyl Phosphate / Q000378:metabolism; D003513:Cycloheximide / Q000494:pharmacology; D005973:Glutamine / Q000008:administration & dosage*; D007555:Isoxazoles / Q000494:pharmacology; D008297:Male; D051379:Mice; D008813:Mice, Inbred ICR; D008930:Mitochondria, Liver / Q000201:enzymology / Q000378:metabolism; D009955:Ornithine Decarboxylase / Q000378:metabolism; D009953:Ornithine-Oxo-Acid Transaminase / Q000378:metabolism; D009963:Orotic Acid / Q000652:urine*
chemical_list: D007555:Isoxazoles; D005973:Glutamine; D002221:Carbamyl Phosphate; D009963:Orotic Acid; D000641:Ammonia; D003513:Cycloheximide; D009953:Ornithine-Oxo-Acid Transaminase; D009955:Ornithine Decarboxylase; D002223:Carbamoyl-Phosphate Synthase (Glutamine-Hydrolyzing); C006303:acivicin